Annual CFF
$58.43 M
+$42.52 M+267.34%
December 31, 2023
Summary
- As of February 8, 2025, HOWL annual cash flow from financing activities is $58.43 million, with the most recent change of +$42.52 million (+267.34%) on December 31, 2023.
- During the last 3 years, HOWL annual CFF has fallen by -$35.43 million (-37.75%).
- HOWL annual CFF is now -46.60% below its all-time high of $109.43 million, reached on December 31, 2021.
Performance
HOWL Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
-$6000.00
+$9.71 M+99.94%
September 30, 2024
Summary
- As of February 8, 2025, HOWL quarterly cash flow from financing activities is -$6000.00, with the most recent change of +$9.71 million (+99.94%) on September 30, 2024.
- Over the past year, HOWL quarterly CFF has dropped by -$47.00 thousand (-114.63%).
- HOWL quarterly CFF is now -100.01% below its all-time high of $110.20 million, reached on June 30, 2021.
Performance
HOWL Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$19.61 M
-$47.00 K-0.24%
September 30, 2024
Summary
- As of February 8, 2025, HOWL TTM cash flow from financing activities is $19.61 million, with the most recent change of -$47.00 thousand (-0.24%) on September 30, 2024.
- Over the past year, HOWL TTM CFF has dropped by -$31.01 million (-61.26%).
- HOWL TTM CFF is now -89.19% below its all-time high of $181.45 million, reached on June 30, 2021.
Performance
HOWL TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
HOWL Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +267.3% | -114.6% | -61.3% |
| 3 y3 years | -37.8% | -100.5% | +23.3% |
| 5 y5 years | +166.7% | -100.5% | +23.3% |
HOWL Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -46.6% | +267.3% | -100.0% | +99.9% | -82.2% | +487.7% |
| 5 y | 5-year | -46.6% | +267.3% | -100.0% | +99.9% | -89.2% | -100.0% |
| alltime | all time | -46.6% | +267.3% | -100.0% | +99.9% | -89.2% | -100.0% |
Werewolf Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$6000.00(-99.9%) | $19.61 M(-0.2%) |
| Jun 2024 | - | -$9.72 M(-148.0%) | $19.65 M(-34.6%) |
| Mar 2024 | - | $20.26 M(+123.3%) | $30.07 M(-48.5%) |
| Dec 2023 | $58.43 M(+267.3%) | $9.07 M(>+9900.0%) | $58.43 M(+15.4%) |
| Sep 2023 | - | $41.00 K(-94.1%) | $50.61 M(-17.9%) |
| Jun 2023 | - | $692.00 K(-98.6%) | $61.65 M(-4.2%) |
| Mar 2023 | - | $48.62 M(+3771.3%) | $64.37 M(+304.7%) |
| Dec 2022 | $15.91 M | $1.26 M(-88.7%) | $15.91 M(+8.3%) |
| Sep 2022 | - | $11.08 M(+224.3%) | $14.69 M(+340.3%) |
| Jun 2022 | - | $3.42 M(+2047.8%) | $3.34 M(-97.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $159.00 K(+318.4%) | $110.12 M(+0.6%) |
| Dec 2021 | $109.43 M(+16.6%) | $38.00 K(-113.8%) | $109.43 M(-39.6%) |
| Sep 2021 | - | -$276.00 K(-100.3%) | $181.27 M(-0.1%) |
| Jun 2021 | - | $110.20 M(<-9900.0%) | $181.45 M(+94.4%) |
| Mar 2021 | - | -$538.00 K(-100.7%) | $93.32 M(-0.6%) |
| Dec 2020 | $93.86 M(+328.4%) | $71.88 M(<-9900.0%) | $93.86 M(+327.1%) |
| Sep 2020 | - | -$97.00 K(-100.4%) | $21.98 M(-0.4%) |
| Jun 2020 | - | $22.07 M(>+9900.0%) | $22.07 M(>+9900.0%) |
| Mar 2020 | - | $0.00 | $0.00 |
| Dec 2019 | $21.91 M | - | - |
FAQ
- What is Werewolf Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Werewolf Therapeutics?
- What is Werewolf Therapeutics annual CFF year-on-year change?
- What is Werewolf Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Werewolf Therapeutics?
- What is Werewolf Therapeutics quarterly CFF year-on-year change?
- What is Werewolf Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Werewolf Therapeutics?
- What is Werewolf Therapeutics TTM CFF year-on-year change?
What is Werewolf Therapeutics annual cash flow from financing activities?
The current annual CFF of HOWL is $58.43 M
What is the all time high annual CFF for Werewolf Therapeutics?
Werewolf Therapeutics all-time high annual cash flow from financing activities is $109.43 M
What is Werewolf Therapeutics annual CFF year-on-year change?
Over the past year, HOWL annual cash flow from financing activities has changed by +$42.52 M (+267.34%)
What is Werewolf Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of HOWL is -$6000.00
What is the all time high quarterly CFF for Werewolf Therapeutics?
Werewolf Therapeutics all-time high quarterly cash flow from financing activities is $110.20 M
What is Werewolf Therapeutics quarterly CFF year-on-year change?
Over the past year, HOWL quarterly cash flow from financing activities has changed by -$47.00 K (-114.63%)
What is Werewolf Therapeutics TTM cash flow from financing activities?
The current TTM CFF of HOWL is $19.61 M
What is the all time high TTM CFF for Werewolf Therapeutics?
Werewolf Therapeutics all-time high TTM cash flow from financing activities is $181.45 M
What is Werewolf Therapeutics TTM CFF year-on-year change?
Over the past year, HOWL TTM cash flow from financing activities has changed by -$31.01 M (-61.26%)